Srivatsan Raghavan

机构：Broad Institute, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Massachusetts Institute of Technology · ORCID：0000-0002-5374-9918

发表论文 417 篇 · 总被引 4733 次 · h-index 28

代表论文

• Evaluating the role of pretraining dataset size and diversity on single-cell foundation model performance (2026 · Nature Methods · 被引 7)
• A compendium of next-generation patient-derived models for diverse cancers (2026 · Nature · 被引 2)
• A dependency map enhanced with next-generation 3D cancer models (2026 · Nature · 被引 1)
• Supplemental Table 5 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2026)
• Supplementary Table S2 from A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2 (2026)
• Supplementary Table S3 from A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2 (2026)